The Vanguard Group 13D and 13G filings for Meridian Bioscience, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-09 11:27 am Purchase |
2022-12-30 | 13G | Meridian Bioscience, Inc. VIVO |
The Vanguard Group | 4,970,105 11.340% |
93,163 (+1.91%) |
Filing |
| 2022-02-10 08:27 am Purchase |
2021-12-31 | 13G | Meridian Bioscience, Inc. VIVO |
The Vanguard Group | 4,876,942 11.210% |
119,227 (+2.51%) |
Filing |
| 2021-02-10 11:28 am Purchase |
2020-12-31 | 13G | Meridian Bioscience, Inc. VIVO |
The Vanguard Group | 4,757,715 11.030% |
155,889 (+3.39%) |
Filing |